Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods
Metabolism-disrupting chemicals (MDCs) are endocrine disruptors with obesogenic and/or diabetogenic action. There is mounting evidence linking exposure to MDCs to increased susceptibility to diabetes. Despite the important role of glucagon in glucose homeostasis, there is little information on the e...
Main Authors: | Reinaldo Sousa Dos Santos, Ignacio Babiloni-Chust, Laura Marroqui, Angel Nadal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/1/231 |
Similar Items
-
In Vitro Assays to Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic β-Cell Model
by: Reinaldo Sousa Dos Santos, et al.
Published: (2022-05-01) -
G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ERα and ERβ in pancreatic beta cells
by: Ignacio Babiloni-Chust, et al.
Published: (2022-06-01) -
Endocrine Disrupting Chemicals: A Challenge to Child Health
by: Geetha Mani, et al.
Published: (2017-03-01) -
Endocrine disruption modeling /
by: Devillers, J. (James), 1956-
Published: (c200) -
How to Differentiate General Toxicity-Related Endocrine Effects from Endocrine Disruption: Systematic Review of Carbon Disulfide Data
by: Nathalie Printemps, et al.
Published: (2022-03-01)